<DOC>
	<DOCNO>NCT02987335</DOCNO>
	<brief_summary>India world 's high prevalence diabetes , expect rise 80 million 2030 . This include many patient lean diabetes , low body mass index ( BMI ) severe complication diabetes . Despite prevalence India country dire health consequence individual disease , little known aetiopathogenesis genotype-phenotype relationship , lean diabetes cluster low birth weight individual , MODY , lipododystrophic disease , type 1 diabetes fibrocalcific disease . While rudimentary test suggest defect insulin secretion action , comprehensive metabolic study perform . It therefore unclear patient treat . The optimal therapeutic adjunct whether suitable oralantidiabetic agent insulin yet determine . Defining metabolic defect 'lean ' diabetes tremendous therapeutic benefit million patient elusive condition .</brief_summary>
	<brief_title>Metabolic Characteristics Lean Diabetes Rural Semi-urban India United States</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Malnutrition</mesh_term>
	<criteria>Age 1945 yr Diabetes duration least one year ( diabetes group ) BMI range : 1622.5 kg/m2 ( individual lean type 1 diabetes nondiabetic control ) ; 22.527 kg/m2 individual type 2 diabetes Negative GAD antibody Present ( &gt; 1.0pmol/l ) Cpeptide response Sustacal challenge Stable moderatetopoor glycemic control ( HbA1c great 8 % ) Able willing provide inform consent . Mentally disable person Major psychiatric disorder medication ( exclude successfully treat depression ) HIV/AIDS History cancer Alcohol substance abuse toxin exposure could associate neuropathy Cushing 's syndrome Pregnancy breastfeeding Untreated uncontrolled hypertension Any Chronic illness require medication History bleed disorder prolong PT PTT Renal disease Liver impairment Prisoners</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>